(Q42201316)

English

Combination therapy with pegylated interferon alpha-2b and adefovir dipivoxil in HBeAg-positive chronic hepatitis B versus interferon alone: a prospective, randomized study

scientific article published on 19 August 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 October 2017

Combination therapy with pegylated interferon alpha-2b and adefovir dipivoxil in HBeAg-positive chronic hepatitis B versus interferon alone: a prospective, randomized study (English)

1 reference

Europe PubMed Central

18 October 2017

chronic hepatitis B

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

Yu-hua Liu

1

1 reference

Europe PubMed Central

18 October 2017

Tao Wu

2

1 reference

Europe PubMed Central

18 October 2017

Ning Sun

3

1 reference

Europe PubMed Central

18 October 2017

Guang-li Wang

4

1 reference

Europe PubMed Central

18 October 2017

Jian-zhi Yuan

5

1 reference

Europe PubMed Central

18 October 2017

Yu-rong Dai

6

1 reference

Europe PubMed Central

18 October 2017

Xiao-hui Zhou

7

1 reference

Europe PubMed Central

18 October 2017

publication date

19 August 2014

1 reference

Europe PubMed Central

18 October 2017

Journal of Huazhong University of Science and Technology. Medical Sciences

1 reference

Europe PubMed Central

18 October 2017

34

1 reference

Europe PubMed Central

18 October 2017

4

1 reference

Europe PubMed Central

18 October 2017

542-547

1 reference

Europe PubMed Central

18 October 2017

https://scigraph.springernature.com/pub.10.1007/s11596-014-1312-2

0 references

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Update on epidemiology of hepatitis B and C in China

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1312-2

21 January 2018

Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/25135724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter study of the effectiveness of interferon alpha-1b (Hapgen) in treating HBeAg positive chronic hepatitis B patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25135724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/25135724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha plus adefovir combination therapy versus interferon-alpha monotherapy for chronic hepatitis B treatment: A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25135724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The role of interferon in the treatment of viral hepatitis and its perspective]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25135724

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11596-014-1312-2

1 reference

Europe PubMed Central

18 October 2017

1 reference

Europe PubMed Central

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42201316&oldid=1935769859"